Data as of Jan 30
| +0.0345 / +3.78%|
The 2 analysts offering 12-month price forecasts for Aveo Pharmaceuticals Inc have a median target of 1.50, with a high estimate of 2.00 and a low estimate of 1.00. The median estimate represents a +58.48% increase from the last price of 0.95.
The current consensus among 2 polled investment analysts is to Sell stock in Aveo Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.